BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32028270)

  • 1. Automatic bi-objective parameter tuning for inverse planning of high-dose-rate prostate brachytherapy.
    Maree SC; Bosman PAN; van Wieringen N; Niatsetski Y; Pieters BR; Bel A; Alderliesten T
    Phys Med Biol; 2020 Apr; 65(7):075009. PubMed ID: 32028270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of bi-objective treatment planning for high-dose-rate prostate brachytherapy-A retrospective observer study.
    Maree SC; Luong NH; Kooreman ES; van Wieringen N; Bel A; Hinnen KA; Westerveld H; Pieters BR; Bosman PAN; Alderliesten T
    Brachytherapy; 2019; 18(3):396-403. PubMed ID: 30718176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPU-accelerated bi-objective treatment planning for prostate high-dose-rate brachytherapy.
    Bouter A; Alderliesten T; Pieters BR; Bel A; Niatsetski Y; Bosman PAN
    Med Phys; 2019 Sep; 46(9):3776-3787. PubMed ID: 31236948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer.
    Fröhlich G; Geszti G; Vízkeleti J; Ágoston P; Polgár C; Major T
    Strahlenther Onkol; 2019 Nov; 195(11):991-1000. PubMed ID: 31482321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards artificial intelligence-based automated treatment planning in clinical practice: A prospective study of the first clinical experiences in high-dose-rate prostate brachytherapy.
    Barten DLJ; Pieters BR; Bouter A; van der Meer MC; Maree SC; Hinnen KA; Westerveld H; Bosman PAN; Alderliesten T; van Wieringen N; Bel A
    Brachytherapy; 2023; 22(2):279-289. PubMed ID: 36635201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of IPSA and HIPO inverse planning optimization algorithms for prostate HDR brachytherapy.
    Panettieri V; Smith RL; Mason NJ; Millar JL
    J Appl Clin Med Phys; 2014 Nov; 15(6):5055. PubMed ID: 25493531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dose and catheter optimization algorithms in prostate high-dose-rate brachytherapy.
    Poulin E; Varfalvy N; Aubin S; Beaulieu L
    Brachytherapy; 2016; 15(1):102-11. PubMed ID: 26561276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating the role of constrained CVT and CVT in HIPO inverse planning for HDR brachytherapy of prostate cancer.
    Sachpazidis I; Hense J; Mavroidis P; Gainey M; Baltas D
    Med Phys; 2019 Jul; 46(7):2955-2968. PubMed ID: 31055834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of inverse optimization algorithms for HDR/PDR prostate brachytherapy treatment planning.
    Dinkla AM; van der Laarse R; Kaljouw E; Pieters BR; Koedooder K; van Wieringen N; Bel A
    Brachytherapy; 2015; 14(2):279-88. PubMed ID: 25447341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two inverse planning algorithms for cervical cancer brachytherapy.
    Fu Q; Xu Y; Zuo J; An J; Huang M; Yang X; Chen J; Yan H; Dai J
    J Appl Clin Med Phys; 2021 Mar; 22(3):157-165. PubMed ID: 33626225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urethra low-dose tunnels: validation of and class solution for generating urethra-sparing dose plans using inverse planning simulated annealing for prostate high-dose-rate brachytherapy.
    Cunha JA; Pouliot J; Weinberg V; Wang-Chesebro A; Roach M; Hsu IC
    Brachytherapy; 2012; 11(5):348-53. PubMed ID: 21937284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A GPU-based multi-criteria optimization algorithm for HDR brachytherapy.
    Bélanger C; Cui S; Ma Y; Després P; Adam M Cunha J; Beaulieu L
    Phys Med Biol; 2019 May; 64(10):105005. PubMed ID: 30970341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the impact of real-time multicriteria optimizers integrated with interactive plan navigation tools for HDR brachytherapy.
    Bélanger C; Poulin É; Cui S; Vigneault É; Martin AG; Foster W; Després P; Cunha JAM; Beaulieu L
    Brachytherapy; 2020; 19(5):607-617. PubMed ID: 32713779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Keeping your best options open with AI-based treatment planning in prostate and cervix brachytherapy.
    Dickhoff LRM; Scholman RJ; Barten DLJ; Kerkhof EM; Roorda JJ; Velema LA; Stalpers LJA; Pieters BR; Bosman PAN; Alderliesten T
    Brachytherapy; 2024; 23(2):188-198. PubMed ID: 38296658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy.
    Morton GC; Sankreacha R; Halina P; Loblaw A
    Brachytherapy; 2008; 7(1):12-6. PubMed ID: 18037356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptation of the CVT algorithm for catheter optimization in high dose rate brachytherapy.
    Poulin E; Fekete CA; Létourneau M; Fenster A; Pouliot J; Beaulieu L
    Med Phys; 2013 Nov; 40(11):111724. PubMed ID: 24320432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the IPSA and HIPO algorithms for interstitial tongue high-dose-rate brachytherapy.
    Choi CH; Park SY; Park JM; Wu HG; Kim JH; Kim JI
    PLoS One; 2018; 13(10):e0205229. PubMed ID: 30286187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dosimetric analysis of different optimization algorithms for three-dimensional brachytherapy for gynecologic tumors].
    Ling B; Chen L; Zhang J; Cao X; Ye W; Ouyang Y; Chi F; Ding Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Apr; 44(4):773-779. PubMed ID: 38708512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric and Radiobiological Evaluation of Hybrid Inverse Planning and Optimization for Cervical Cancer Brachytherapy.
    Matias Ldos S; Palmqvist T; Wolke J; Nilsson J; Beskow C; Maphossa AM; Toma-Dasu I
    Anticancer Res; 2015 Nov; 35(11):6091-6. PubMed ID: 26504034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Penalty weight tuning in high dose rate brachytherapy using multi-objective Bayesian optimization.
    Jafarzadeh H; Antaki M; Mao X; Duclos M; Maleki F; Enger SA
    Phys Med Biol; 2024 May; 69(11):. PubMed ID: 38670145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.